Lv11
88 积分 2026-07-27 加入
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
10天前
已完结
Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome
13天前
已完结
Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug‐induced liver injury: A multicenter, randomized, phase II trial
1个月前
已完结
Intestinal failure among adults and children: Similarities and differences
2个月前
已完结
Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN
2个月前
已完结
Selective agonism of liver and gut FXR prevents cholestasis and intestinal atrophy in parenterally fed neonatal pigs
2个月前
已完结
Incidence, Prevention, and Treatment of Parenteral Nutrition–Associated Cholestasis and Intestinal Failure–Associated Liver Disease in Infants and Children
2个月前
已完结
Selective Agonism of Liver and Gut FXR Prevents Cholestasis and Intestinal Atrophy in Parenterally Fed Neonatal Pigs
2个月前
已完结
Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation
皖公网安备34019202002308
